Dissertations / Theses on the topic 'Novel heterocyclic compounds'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 49 dissertations / theses for your research on the topic 'Novel heterocyclic compounds.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
MacDonald, Ranald John. "Novel routes to heterocyclic Azo compounds." Thesis, University of Edinburgh, 2011. http://hdl.handle.net/1842/5787.
Full textEmans, John. "Synthesis of novel heterocyclic polymers." Thesis, University of St Andrews, 1987. http://hdl.handle.net/10023/15299.
Full textNyoni, Dubekile. "Application of the Baylis-Hillman methodology in the construction of novel heterocyclic derivatives." Thesis, Rhodes University, 2008. http://eprints.ru.ac.za/1134/.
Full textPhilbin, Simon Patrick. "Studies of novel nitro-substituted nitrogen heterocyclic compounds." Thesis, Brunel University, 2001. http://bura.brunel.ac.uk/handle/2438/2165.
Full textAl-Suwaidan, I. A. "Heterocyclic compounds as novel substrates for glutathione transferase." Thesis, University of Bradford, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.378114.
Full textTaher, Abutariq. "Novel cyclisations of nitro-compounds for heterocyclic synthesis." Thesis, Loughborough University, 2001. https://dspace.lboro.ac.uk/2134/34705.
Full textKilloran, P. M. "Development of novel heterocyclic compounds as vascular targeting agents." Thesis, University of Salford, 2015. http://usir.salford.ac.uk/36856/.
Full textIannarelli, Paul M. "Routes to novel azo compounds." Thesis, University of Edinburgh, 2008. http://hdl.handle.net/1842/3492.
Full textRogers, James William. "1-benzotriazolyl-2-propynones as novel 1,3-biselectrophiles, benzotriazole-assisted thioacylation and synthesis of energetic materials." [Gainesville, Fla.] : University of Florida, 2006. http://purl.fcla.edu/fcla/etd/UFE0013389.
Full textGrisle, Roger Anthony. "Synthesis of novel heterocyclic difluoro monomers via the chemistry of reissert compounds." Thesis, This resource online, 1992. http://scholar.lib.vt.edu/theses/available/etd-05042010-020216/.
Full textElla-Menye, Jean-Rene. "Synthesis of Novel Chiral Heterocyclic Compounds for Antibacterial Agents and Peptidomimetics." ScholarWorks@UNO, 2007. http://scholarworks.uno.edu/td/611.
Full textGuilani, Bardia. "Synthesis of novel heterocyclic polymers via the chemistry of Reissert compounds." Thesis, Virginia Tech, 1990. http://hdl.handle.net/10919/42072.
Full textThe chemistry of a well established class of compounds, known as Reissert compounds, was used to prepare several novel N-heterocyclic polymers. Initially, alkylation of quinoline Reissert compounds was closely examined to test the feasibility of the use of such compounds as difunctional monomers. An A-B and an A-A monomer were then prepared by the reaction of quinoline with p-formylbenzoyl chloride and isophthaloyl chloride, respectively. The former monomer could be polymerized interfacially to afford a low molecular weight polyester exhibiting Tg of 190°C.
Several novel bis-isoquinolines were prepared using an en amine reaction reported by Minter and Re.52 One of these bis-isoquinolines was used to prepare two novel bis-Reissert compounds which could be polymerized with several dialdehydes to obtain high molecular weight N-heterocyclic polyesters. Cleavage of the ester groups afforded a novel N-heterocyclic polyalcohol. It was observed that circumvention of a rearrangement reaction particular to Reissert compounds by molecular design led to the synthesis of N-heterocyclic polyesters that had the highest molecular weights and intrinsic viscosities.
A novel N-heterocyclic difluorodiketone was prepared in four steps using the enamine reaction of Minter and Re52 and Reissert compound chemistry. The diketone was polymerized via standard techniques 72 to afford several novel poly(N-heteroaryl-ether-ketones) with high glass transition temperatures and thermal stabilities. Thus, polymerization of 1,4-bis(4-fluorobenzoyl)isoquinoline with biphenol yielded a poly(ether-ketone) with an intrinsic viscosity of 0.34 dl/g. This polymer showed Tg at 209°C and was stable up to 500°C in air.
Master of Science
陳淑妤 and Suk-yu Florence Chan. "Novel synthesis and chemistry of 1, 4, 2-dithiazolium salts." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1988. http://hub.hku.hk/bib/B30426352.
Full textYar, Muhammad. "Applications of Vinyl Sulfonium Salts in a Novel Synthesis of Heterocyclic Compounds." Thesis, University of Bristol, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.520190.
Full textShawcross, Andrew Paul. "The synthesis of novel heterocyclic compounds and observations on the Vilsmeier reaction." Thesis, University of Newcastle Upon Tyne, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.328112.
Full textMcFadden, Helen Georgina, and n/a. "Synthesis and herbicidal properties of some pyrazole and pyrimidine heteocycles." University of Canberra. Biomedical Sciences, 1992. http://erl.canberra.edu.au./public/adt-AUC20060918.160845.
Full textFischer, Kristapher Edward, and University of Lethbridge Faculty of Arts and Science. "Synthesis and characterization of novel cyclophanes from 5,5'-bi(isobenzofuran)." Thesis, Lethbridge, Alta. : University of Lethbridge, Faculty of Arts and Science, 2005, 2005. http://hdl.handle.net/10133/255.
Full textx, 119 leaves : ill. ; 29 cm.
Rose, Nathan Rolf. "Synthesis of novel coumarin derivatives as potential inhibitors of HIV-1 protease." Thesis, Rhodes University, 2007. http://hdl.handle.net/10962/d1007220.
Full textKMBT_363
Adobe Acrobat 9.54 Paper Capture Plug-in
Rashamuse, Thompho Jason. "Studies towards the synthesis of novel, coumarin-based HIV-1 protease inhibitors." Thesis, Rhodes University, 2008. http://eprints.ru.ac.za/1332/.
Full textHodson, Luke. "The synthesis of novel kinase inhibitors using click chemistry." Thesis, Stellenbosch : Stellenbosch University, 2014. http://hdl.handle.net/10019.1/86704.
Full textENGLISH ABSTRACT: Cancer is the leading cause of death on the planet, killing an estimated 8.2 million people in the year of 2012.The disease is associated with two families of genes, namely oncogenes and tumour suppressor genes. The hallmarks of cancer pathogenesis include gene amplification, point mutations or chromosomal rearrangements within these genes. Kinases are responsible for the reversible phosphorylation of proteins, which plays a significant and extensive role in cellular signal transduction. Aberrant kinase activity provokes overexpression, mutations and chromosomal translocation and results in the onset of onco- and tumorogenesis, ultimately leading to cancer. Inactivation of this class of enzyme is thus critical as it would result in the suppression of these unwanted activities. For this, researchers have developed kinase inhibitors, specifically targeting these proteins and thus inhibiting signal transduction pathways and tumour growth. This has resulted in great successes, particularly in the case of the commercial inhibitor, imatinib. However, resistance to approved therapeutic agents through mutations has resulted in the search for more potent and selective inhibitors to overcome these obstacles. This project involved the synthesis of bioactive heterocycles linked to 1,2,3-triazoles using either a C-C or C-N bond forming strategy. The synthetic methodology followed included the use of Sonogashira coupling reactions between3-bromoquinoline, 7-chloro-4-iodoquinoline, 4-bromoisoquinolineand5-bromoisoquinolineand trimethylsilylacetylene (TMSA), followed by deprotection of the TMS group to yield heterocycles bearing terminal alkynes. The synthesis of both benzyl azide and 2-(azidomethyl)pyridine as azide fragments, allowed for subsequent coupling of the synthesized azide and alkyne fragments through copper-mediated click chemistry, affording a library of 1,4-substituted 1,2,3-triazole based reversible kinase inhibitors. Synthesis of a second library of o-, m- and p-substituted nitro benzyl azides, allowed for both copper- and ruthenium-mediated click reactions, between the alkynes and nitro benzyl azides synthesized, to yield 1,4- and 1,5-substituted 1,2,3-triazoles, respectively. Finally, reduction of the incorporated o-, m- and p- substituted nitro group, and acylation of the resultant amine with acryloyl chloride, resulted in the incorporation of the important Michael acceptor moiety required for irreversible inhibition. This afforded a library of both reversible and potential irreversible triazole-based kinase inhibitors through efficient copper- and ruthenium-mediated click chemistry. Biological screening and activity assays against the wildtype, and two mutated forms of the EGFR kinase, were undertaken with these synthesized compounds.A number of synthesized inhibitors showed good selectivity for the mutated forms of the EGFR kinase only.The most potent inhibitor N-{2-{[4-(isoquinolin-4-yl)-1H-1,2,3-triazol-1-yl]methyl}phenyl}acrylamide,displayed efficacy in the low μM range - comparable to that of the FDA approved drug, gefitinib. The synthetic methodology derived in this project could be applied to the use of biological space probes with further investigatory research. Furthermore, from the biological screening results obtained, and the selectivity profile shown by these inhibitors, the synthesis of a second generation library of compounds is an additional research possibility.
AFRIKAANSE OPSOMMING: Kanker is die hoof oorsaak van sterftes ter wêreld, wat verantwoordelik is vir die dood van ongeveer 8.2 miljoen mense in die jaar 2012. Die siekte word geassosieer met twee geenfamilies, naamlik onkogene en gewasonderdrukkingsgene. Die kenmerke van kanker pathiogene behels geenversterking, puntmutasies of chromosomale herrangskikking binne in die gene. Kinase is verantwoordelik vir die omkeerbare fosforilering van proteine wat 'n uiters belangrike rol in sellulere sein transduksie speel. Abnormale kinase aktiwiteit lei tot ooruitdrukking, mutasies en chromosomale translokasie wat tot die ontwikkeling van onko- en gewasgroei en wat eindelik tot kanker lei. Deaktivering van die klas van ensieme is dus krities want dit sal die ongewenste abnormale aktiwiteite onderdruk. As gevolg van die bogenoemde, het navorsers kinase inhibeerders ontwikkel wat die spesifieke protein teiken en hiermee die sein transduksie roete asook gewas groei inhibeer. Hiermee het die sukses van inhibeerders veral die kommersiele inhibeerder, imatinib, grootliks toegeneem. Oor die afgelope jare het die belangstelling in die ontwikkeling van meer selektiewe en kragtige inhibeerders toegeneem as gevolg van die weerstand wat goedgekeurde terapeutiese middels opbou. In hierdie projek is daar gebruik gemaak van 'n C-C of C-N bindingsvorming strategie om bioaktiewe heterosikliese molekules te sintetiseer wat gekoppel is aan 1,2,3-triasool funksionele groepe. Die sintetiese metode maak gebruik van Sonogashira reaksies vir die 3-bromo-kwinolien, 7-chloro-4-iodokwinolien, 4-bromoisokwinolien en 5-bromoisokwinolien met trimetielsilielasetileen (TMSA), gevolg met die ontskerming van die TMS-groep om die terminale alkyn op die heterosiklusse te ontbloot. Die asied fragmente, bensiel asied en 2-(asidometiel)piridien, was toe gesintetiseer om met die gevormde heterosiklus alkyne 'n koper ondersteunende kliek chemie te ondergaan. 'n Reeks van 1,4-digesubstitueerde 1,2,3-triasool gebaseerde omkeerbare kinase inhibitore is toe gevorm. 'n Tweede reeks met o-, m-, en p- gesubtitueerde nitro bensiel asiede was gesintetiseer om 1,4- en 1,5- digesubtitueerde 1,2,3-triasole te sintetiseer met behulp van koper- en ruthenium ondersteunende kliek chemie. Laastens was die o-, m-, en p- nitro groepe gereduseer om 'n primêre amien te vorm. Die gevormende amien het 'n asileringsreaksie met akriloïel chloried ondergaan om die kern, die Michael akseptor, te inkorporeer. Die Michael akseptor word benodig om 'n onomkeerbare inhibitoriese aktiwiteit te kan uitvoer. Die projek het dus met behulp van kliek chemie, twee 1,2,3-triasool reekse gelewer wat omkeerbare en onomkeerbare inhibitoriese aktiwiteit kan uitvoer. Die verbindings gesintetiseerd in hierdie projek het keuringstoetse ondergaan teen die wilde tipe en teen twee gemuteerde forme van die EGFR kinase ensiem. Van hierdie verbindings het goeie selektiwiteit vertoon teenoor die gemuteerde EGFR kinase ensiem. Die mees aktiewe inhibeerder, N-{2-{[4-isokwinolin-4-iel)-1H-1,2,3-triasool-1-iel]feniel}akrielamied, het aktiwiteit in die lae μM reeks vertoon. Dié inhibisie waarde is vergelykbaar met die FDA goedgekeurde medikasie, gefitinib. In hierdie projek is sintetiese metodes ontwikkel wat toegepas kan word op meer intensiewe biologiese ondersoeke en asook meer navorsing. Die resultate vekry van die biologiese aktiwiteit, asook die verbindings se selektiwiteit, gee die moontlikheid vir die ontwikkeling en sintese van 'n tweede generasie verbindings.
Sigauke, Lester Takunda. "An in-silico investigation of Morita-Baylis-Hillman accessible heterocyclic analogues for applications as novel HIV-1 C protease inhibitors." Thesis, Rhodes University, 2015. http://hdl.handle.net/10962/d1017913.
Full textTukulula, Matshawandile. "The design and synthesis of novel HIV-1 protease inhibitors." Thesis, Rhodes University, 2009. http://eprints.ru.ac.za/1563/.
Full textDulla, Balakrishna [Verfasser], and Oliver [Akademischer Betreuer] Reiser. "Synthesis and pharmacological characterization of novel N & O containing heterocyclic compounds as potential therapeutic agents / Balakrishna Dulla. Betreuer: Oliver Reiser." Regensburg : Universitätsbibliothek Regensburg, 2013. http://d-nb.info/1059003708/34.
Full textLee, Yi-Chen. "Studies towards the development of novel HIV-1 integrase inhibitors." Thesis, Rhodes University, 2010. http://hdl.handle.net/10962/d1005022.
Full textSherwood, Alexander M. "Design, Synthesis and Biological Evaluation of Novel Compounds with CNS-Activity Targeting Cannabinoid and Biogenic Amine Receptors." ScholarWorks@UNO, 2014. http://scholarworks.uno.edu/td/1831.
Full textWazeerud-Din, Idris. "Synthetic Approaches towards Novel Isoform Selective PI3K Inhibitors and Their Biological Activities against Prostate Cancer Cells." DigitalCommons@Robert W. Woodruff Library, Atlanta University Center, 2018. http://digitalcommons.auctr.edu/cauetds/143.
Full textRayala, Ramanjaneyulu. "Design and Synthesis of Novel Nucleoside Analogues: Oxidative and Reductive Approaches toward Synthesis of 2'-Fluoro Pyrimidine Nucleosides." FIU Digital Commons, 2015. http://digitalcommons.fiu.edu/etd/2172.
Full textVerespy, Stephen S. III. "Probing Allosteric, Partial Inhibition of Thrombin Using Novel Anticoagulants." VCU Scholars Compass, 2016. http://scholarscompass.vcu.edu/etd/4431.
Full textWaterfield, P. C. "Novel C-organostannyl heterocycles." Thesis, University of Bath, 1988. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.384138.
Full textBadyal, Karanbir. "The use of organotellurium heterocycles as precursors for novel organometallic compounds." Thesis, Aston University, 1996. http://publications.aston.ac.uk/9690/.
Full textKilburn, John Paul. "Novel solid-phase synthesis strategies for the preparation of heterocycles and guanidines." Thesis, Open University, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.247056.
Full textCabarrocas, Duran Gemma. "Aproximacions sintètiques per a la preparació estereoselectiva de noves quinolil i pirazolilglicines i per a la preparació en fase sòlida de llibreries de benzotiazoles, 1,2,4-triazines i benzimidazoles." Doctoral thesis, Universitat de Girona, 1999. http://hdl.handle.net/10803/8057.
Full textThese work have been divided in two sections. In the first section, a new and efficient methodology towards the stereocontrolled synthesis of novel -acetylenic ketones containing a masked -amino acid functionality in enantiomerically pure form has been developed. This new chiral building block is the starting material for the synthesis of enantiomerically pure quinolyl and pyrazolylglycines, important structures with potential biological activity and very useful for the synthesis of peptidomimetics. The methods begins from the Garner's aldehyde and takes place through an alkyne derivative via a carbonyl-alkyne homologation reaction. Condensation of the lithium acetylide at low temperatures with different aldehydes yielded the corresponding propargyllic alcohol derivatives in good yields, which under mild oxidative conditions gave the corresponding acetylenic ketones algmost quantitatively.In the second part of this work, the ability of alkylsulfonyl groups as efficient leaving groups in heteroaromatic mucleophilic ipso-substitution reactions has been studied. The rational behind this study has been the possibility of transferring the developed methodology to the solid support and thus to synthesize in a parallel fashion a small library of molecularly diverse heterocycles with potential biological interest. An in solution optimised methodology has been successfully transferred to the solid support and a small library of molecularly diverse benzothiazoles (-excedent heterocylces) was prepared in a parallel fashion in good overall yields and purities of the final products.
Ros, Blanco Laia. "Disseny i síntesi de noves quimioteques de potencials inhibidors d’entrada del VIH." Doctoral thesis, Universitat Ramon Llull, 2011. http://hdl.handle.net/10803/31981.
Full textEl programa del síndrome de la inmunodeficiencia adquirida (SIDA o sida) de las Naciones Unidas estimó a finales de 2008 que más de 33 millones de personas en todo el mundo vivían con el virus de la inmunodeficiencia humana (VIH). En el estudio de las dianas terapéuticas contra el agente etiológico del sida se han validado como tales los correceptores CXCR4 y CCR5 de unión y fusión del virus a la célula huésped. Actualmente existe un inhibidor de entrada y uno de fusión para el tratamiento de la infección por este retrovirus, aunque ninguno de ellos inhibe el correceptor CXCR4. Ello, unido a la capacidad del virus de desarrollar resistencia a los fármacos actuales, hace necesaria la búsqueda de nuevas familias de compuestos que le hagan frente. El Grup d’Enginyeria Molecular (GEM) del IQS ha descrito previamente una quimioteca combinatoria de análogos del AMD3100, el candidato más activo, formados por unidades estructurales polinitrogenadas (que consisten en un heterociclo nitrogenado, una serie de eslabones metilénicos y un grupo amina primaria terminal) unidas a un espaciador p xililénico. La selección de esta quimioteca llevó a la identificación de un nuevo candidato con dos centros quirales con actividad submicromolar contra el VIH. Este trabajo presenta diversas modificaciones estructurales sobre ambos candidatos, en la búsqueda de nuevos inhibidores potenciales del correceptor de entrada CXCR4. En primer lugar, para rebajar la basicidad del AMD3100, se han substituido sus anillos ciclámicos por sistemas pirido[2,3 d]pirimidínicos, en la síntesis de los cuales se tiene mucha experiencia en el GEM. La baja solubilidad en disolventes comunes de algunos de los compuestos obtenidos se presenta como un grave inconveniente para su desarrollo como fármaco. Por otra parte, teniendo en cuenta el diseño racional descrito anteriormente en el grupo de investigación, se amplía la quimioteca con el objetivo de evaluar el efecto de la distancia entre átomos de nitrógeno y la presencia de mayor impedimento estérico entre el espaciador aromático y el nitrógeno que está directamente unido a él. Aunque no se ha conseguido mejorar la actividad de la estructura de referencia, los compuestos obtenidos presentan actividades satisfactorias. Asimismo, se obtienen los tres estereoisómeros del candidato con actividad submicromolar y se evalúa la actividad antiviral por separado. Finalmente, se lleva a cabo un diseño de novo de fármacos basado en la estructura para buscar nuevos candidatos que permitan abrir la puerta a otras familias de compuestos con actividad anti-VIH, a través de la enumeración de la quimioteca virtual, la selección y la posterior síntesis.
The Joint United Nations Programme on Acquired Immunodeficiency Syndrome (AIDS) estimated in 2008 that more than 33 million people around the world lived with the human immunodeficiency virus (HIV). HIV cell fusion and entry coreceptors CXCR4 and CCR5 have been validated as targets for therapeutic intervention. Nowadays, there is one entry and one fusion inhibitor available for the treatment of this retrovirus infection, although none of them inhibits CXCR4 coreceptor. Due to this fact, added to the virus’ capacity of developing resistance to actual drugs, the search of new families of compounds facing up to these situations becomes necessary. The Grup d’Enginyeria Molecular (GEM) at IQS previously described a combinatorial library of analogues of the currently most active lead AMD3100, whose polinitrogenated building block consisted of a nitrogen-containing heterocycle, a saturated chain spacer and a terminal primary amine group, bonded to a p xylylene spacer. Library selection led to the identification of a new lead with two chiral centres and submicromolar activity against HIV. This work presents various structural modifications on both leads, looking for new potential CXCR4 inhibitors. First of all, in order to reduce basicity of AMD3100, cyclam rings were substituted by pyrido[2,3 d]pyrimidinic systems, whose synthesis has been widely studied at GEM. Low solubility in common solvents of some of the obtained compounds remains as a great inconvenience for their development as a drug. Furthermore, regarding the rational design previously described by the research group, the library has been expanded with the aim of evaluating the effect of the distance between nitrogen atoms and the steric effects between the linker and the nitrogen atom directly connected to it. Although biological activities do not improve the lead’s one, the obtained compounds present interesting activities. Moreover, the three stereoisomers of the lead compound with submicromolar activity have been synthesised and their activity has been evaluated separately. Finally, a de novo structure based drug design has been carried out looking for new hits allowing to identify new families of compounds with anti-HIV activity, by enumeration of the virtual library, selection of candidates and their synthesis.
Khramov, Dimitri Mikhailovich 1981. "Novel N-heterocyclic carbenes: applications in materials chemistry and catalysis." Thesis, 2008. http://hdl.handle.net/2152/4006.
Full texttext
An, Deqiang. "Novel calixpyrrole-like anion receptors." Thesis, 2004. http://hdl.handle.net/2152/1183.
Full textAn, Deqiang Sessler Jonathan L. "Novel calixpyrrole-like anion receptors." 2004. http://wwwlib.umi.com/cr/utexas/fullcit?p3139181.
Full textHlungwani, Isaac. "Design, synthesis and biological evaluation of novel tetrasubstituted quinoline-3-carboxamides derivatives." Diss., 2020. http://hdl.handle.net/11602/1558.
Full textDepartment of Chemistry
Quinolines are well known naturally occurring heterocyclic compounds with nitrogen as a heteroatom. Quinolines are also one of the major classes of naturally occurring compounds and the interest in their chemistry is due to the wide range of their biological activities. The objective of the project was the synthesis of novel tetra-substituted quinoline-3carboxamides and subsequent transformation to other novel derivatives and evaluation of their biological activities against malaria and cytotoxicity. In achieving the objective, 2-chloroquinoline-3-carbaldehyde analogues 54A-G were synthesised from the reaction of acetanilides 53A-G and acetic acid. Knoevenagal reaction of 2chloroquinoline-3-carbaldehydes 54A-G with thiazolidinedi-2,4-one 62 provided 2chloroquinoline-3-methylene thiazolidinedi-2,4-one 55A-G which then underwent nucleophilic substitution reaction with sodium azide and afforded (Z)-5-((tetrazolo [1,5a] quinoline-4-yl) methylene) thiazolidinedi-2,4-one 56A-F. (Z)-ethyl-2-(2-5-((7bromotetrazolo [1,5a] quinolin-4-yl) methylene-2,4-dioxothiazolidin-3-yl) acetamido) acetate 57 was synthesised from the reaction of (Z)-5-((7-bromotetrazolo [1,5a] quinoline-4-yl) methylene) thiazolidinedi-2,4-one 56D and ethyl-2-(2-chloroacetamido) acetate 65. The structures of the compounds were characterised by 1D NMR (1H, 13C, and DEPT 135), IR spectroscopy, elemental analysis and high-resolution mass spectroscopy. Novel selected synthesised quinoline compounds were evaluated of in vitro for two biological assays; namely anti-malarial activity and cytotoxicity. The anti-malaria activities of the novel quinoline compounds against 3D7 strain of the malaria parasite Plasmodium falciparum displayed that 2,6-dichloroquinoline-3-methylene thiazolidinedi-2,4-one 55C, (Z)-5-((7-fluorotetrazolo [1,5a] quinoline-4-yl) methylene) thiazolidinedi-2,4-one 56B and (Z)-5((7-ethoxytetrazolo [1,5a] quinoline-4-yl) methylene) thiazolidinedi-2,4-one 56F are potential malaria drugs since they reduced the percentage parasite viability to 25.80, 12.40 and 20.40 respectively. These results were further substantiated by their IC50 values 0.40, 0.04 and 0.50 µg/mL. Compound 56B displayed the highest cytotoxicity activity against human cervix adenocarcinoma cells displaying percentage viability of 14.22 %. Compounds 56F and 56C displayed moderate cytotoxicity activity at 56.60 and 59.81 % viability.
NRF
Johnson, Myron Mario. "The development of novel synthetic methodology for the synthesis of oxygenated heterocycles." Thesis, 2014. http://hdl.handle.net/10539/14963.
Full textKamplain, Justin Wade 1980. "Novel N-heterocyclic carbene architectures for use in carbene based polymers and redox swithcable : catalysis." 2008. http://hdl.handle.net/2152/17900.
Full texttext
Ferreira, João Paulo de Sousa. "Novel heterocyclic quinoline/quinolone-based compounds as acetylcholinesterase inhibitors and antioxidant agents." Master's thesis, 2019. http://hdl.handle.net/10773/30140.
Full textA doença de Alzheimer representa cerca de 60 a 80% dos casos de demência afetando principalmente indivíduos com idades superiores a 65 anos. Esta patologia é caracterizada, a nível molecular, pela presença de placas senis (agregados de péptidos de Aβ amilóide) e agregados neurofibrilares (NFTs). Além disso, diversos estudos experimentais têm revelado que a enzima acetilcolinesterase (AChE) participa no desenvolvimento desta patologia, culminando na formação de NFTs e placas senis. O stress oxidativo é uma causa e consequência desta patologia, ativando vias de sinalização que promovem a agregação dos péptidos Aβ, que por sua vez, são detetados pelas células da microglia, levando à produção de radicais livres incluindo óxido nítrico (NO• ) que, por sua vez, contribuem para a neuroinflamação marcada nesta patologia. Neste contexto, o desenvolvimento de inibidores da AChE e de antioxidantes, nomeadamente como agentes captadores desses radicais, continuam a merecer atenção por parte dos investigadores. O presente trabalho teve por objetivo a síntese, caracterização estrutural (espectroscopia de ressonância magnética nuclear (RMN) mono- ( 1H e 13C) e bidimensionais (HMBC e HSQC), espetrometria de massa, espetrometria de massa de alta resolução e raio-x) de (aril)(furo[3,2-c]quinolin-2-il)metanonas, 3- (3-aril-4,5-di-hidro-1H-pirazol-5-il)-4-cloroquinolinas e ,a título exploratório, de (E)-3-(2-hidroxifenil)-5-(4-metoxiestiril)isoxazol para avaliação da atividade inibitória da AChE e antiradicalar. As atividades anticolinérgicas e antiradicalar dos compostos sintetizados foram avaliadas recorrendo aos métodos de Ellman e de avaliação da capacidade de captação dos radicais (ácido 2,2'-azino-bis(3-etilbenzotiazolina-6-sulfónico) (ABTS+•) e NO• , respetivamente. Sempre que possível, os valores obtidos foram expressos em função da concentração de composto que promoveu a inibição de 50% da atividade enzimática ou que promoveu 50% de captação dos radicais (IC50), respetivamente, para serem estabelecidas algumas relações estruturaatividade biológica. As (aril)(furo[3,2-c]quinolin-2-il)metanonas não se mostraram efectivas como agentes antiradicalares, no entanto dois derivados exibiram atividades inbitórias da AChE (IC50 < 100 µM). As 3-(3-aril-4,5-di-hidro-1H-pirazol-5-il)-4- cloroquinolinas e o (E)-3-(2-hidroxifenil)-5-(4-metoxiestiril)isoxazol foram bons agentes captadores do ABTS+• no entanto não foram muito efetivos na captação do NO• , apresentando para a maior parte dos derivados IC50 > 700 µM. As 3-(3- aril-4,5-di-hidro-1H-pirazol-5-il)-4-cloroquinolinas apresentaram atividades inibitórias de AChE promissoras com maior parte dos derivados apresentando IC50 < 100 µM, enquanto o (E)-3-(2-hidroxifenil)-5-(4-metóxiestiril)isoxazol não foi muito efetivo contra esta enzima. Os resultados evidenciaram que alguns compostos sintetizados apresentaram potencial como inibidores da AChE e como agentes antioxidantes.
Mestrado em Bioquímica
Muñoz, Alberto. "The Development of Novel N-Heterocyclic Carbenes and Tools for Assessing Structural Variation Effects Upon Catalyst Reactivity." Thesis, 2018. https://doi.org/10.7916/D8N02QC9.
Full textPeters, Byron Kennedy. "Synthesis of novel tetrahydroisoquinoline chiral ligands for application in asymmetric transfer hydrogenation." Thesis, 2010. http://hdl.handle.net/10413/5428.
Full textThesis (M.Sc.)-University of KwaZulu-Natal, Westville, 2010.
Moshapo, Paseka Thendo. "Synthesis of sulfoxide and sulfone mycothiol bioisosteres and novel carbohydrate-based thiochromans." Thesis, 2013. http://hdl.handle.net/10210/8754.
Full textInhibition of mycothiol biosynthesis pathway has attracted attention from chemists and biochemists who aim to develop novel anti-TB drugs. A possible route to inhibit the production of mycothiol in cells may be via the inhibition of enzymes involved in the biosynthetic pathways. Molecular analogues that mimic mycothiol and containing tetrahedral-forming functional groups have been reported to show activity against mycothiol biosynthesis by inhibiting the enzymes in the mycothiol biosynthetic pathway...
"Synthesis of novel benzimidazole derivatives and their platinum (II) complexes." Thesis, 2010. http://hdl.handle.net/10413/2614.
Full textThesis (PhD.)-University of KwaZulu-Natal, Pietermaritzburg, 2010.
Nkosi, S'busiso Mfan'vele. "Synthesis of novel quinoline derivatives and their cytotoxicity in A549 lung cancer cells." Thesis, 2017. http://hdl.handle.net/10321/2675.
Full textQuinoline and its derivatives represent an important class of nitrogen-containing heterocylces as they are useful intermediates in organic synthesis and possess a broad spectrum of biological activities, such as anti-asthmatic, anti-inflammatory and anti-malarial activity. Hence, synthesis of novel compounds with potent biological activities is important in medicine. Significant research is directed into the development of new quinoline based structures and new methods for their preparations. In the past, synthesis of complex molecules was accomplished by step-wise reaction. This was time consuming and yield was generally low. Nowadays, multi-component reactions (MCRs) are being used since three or more substrates can be reacted in a one-pot reaction. Therefore yields are higher and the reaction is more efficient. In this research investigation novel quinoline derivatives, using the multi-component reaction protocol, were synthesized. After characterization of the product by several spectroscopic techniques, the biological potential of these compounds were assessed using lung cancer cell lines, bacteria and molecular modeling in an enzymatic system. In the synthetic part of this study, the first step was the preparation of the starting compound 2- chloro-3-formyl quinoline for which the Vilsmeier-Haack cyclisation protocol was used. The cyclisation was carried out by combining DMF and POCl3 at 5°C to form an electrophile which then reacted in situ with N-phenylacetamide at 100ºC to afford 2-chloro-3-formyl quinoline in high yield (95%). This was followed by the synthesis of a series of novel quinoline derivatives in a MCR system comprising 2- chloro-3-formyl quinoline, malononitrile, aromatic amines and dimethyl acetylenedicarboxylate in the presence of a catalytic amount of triethylamine. Valuable features of this routine included high yields, extensive substrate range and straight forward procedures. Eight novel poly-functionalised dihydropyridine quinoline derivatives were synthesized, purified and characterized. The outline for the synthesis of poly-functionalised dihydropyridine quinoline derivatives is presented graphically in Scheme 1. Scheme 2 shows the eight compounds synthesized and used subsequently for further studies. . Step 1 CH3 a N O H CHO N Cl Step 2 CHO CN N Cl CN NH2 R O OCH3 b OCH3 O MeO2C MeO2C N Cl CN N NH2 R = m-CH3, o-OCH3, p-Cl, m,p-Cl, o-F, m-F, p-F R Reaction Conditions: a. DMF, POCl3 b. Et3N, EtOH Scheme 1: Graphical representation for the synthesis of poly-functionalised dihydropyridine quinoline derivatives The novel eight compounds were screened for their potential activity in lung cancer cell lines. A549 cells were incubated for 24 hours with a range of concentrations of each compound, in triplicate, in a micro-titre plate together with an untreated control. Each experiment was conducted twice on separate occasions; the results from the first set matched the repeated experiment. The cells were then incubated (37ºC, 5% CO2) with the MTT substrate for 4 hours. Thereafter all supernatants were aspirated and DMSO was added to the wells. Finally the optical density was measured at 570 nm at a reference wavelength of 690 nm with an ELISA plate reader. The net MTT dependant absorbance (optical density) of each sample was calculated by subtracting the average absorbance of the blank from the average absorbance of each sample. Data were represented as mean optical density plus or minus the standard deviation. Four of the synthesized compounds (A1-A8) were evaluated for their cytotoxicity activities. The anti-cancer assay indicated that poly-functionalised dihydropyridine quinoline compounds, A2, A3 and A4 have good potential as anti-cancer drugs. Among them, A2 and A4 proved to be dose dependent with A4 having the highest toxicity at 250 µM and A8 having the highest toxicity at 125, 250 and 500 µM, whereas A1, A5, A6 and A7 were not cytotoxic. O H3CO H3CO O N Cl CN NH2 O H3CO H3CO O N Cl CN N NH2 OCH3 O H3CO H3CO O N Cl CN N NH2 O H3CO H3CO O N Cl CN NH2 CH3 Cl A1 A2 A3 A4 O H3CO H3CO O N Cl CN N NH2 F O H3CO H3CO O N Cl CN N NH2 O H3CO H3CO O N Cl CN NH2 O H3CO H3CO O N Cl CN N NH2 F Cl F Cl A5 A6 A7 A8 Scheme 2: Structures of novel poly-functionalised dihydropyridine quinoline derivatives by MCRs Since molecular docking is a key tool in structural molecular biology and computer-assisted drug design, these compounds were subjected to molecular docking and the binding mode for the compounds, within the active site of the protein, was analyzed. Docking of A1 to Human mdm2 protein provided insights into the binding regions. Three hydrogen bonds were formed between GLU 25 (2.7 Å distance), LEU 27 (3.2 Å distance) and LEU 54 (3.2 Å distance) atoms with binding energy of -8.91 kcal/mol. Docking of A1 with Human mdm2 indicated the lowest binding energy thereby showing strong affinity of the ligand molecule with the receptor which has been stabilized by strong hydrogen bond interactions in the binding pocket. This confirms that A1 is a better inhibitor for E3 ubiquitin-protein ligase mdm2 than all the other compounds tested (A2-A8). Further, the eight novel poly-functionalised dihydropyridine quinoline derivatives were evaluated for their antibacterial activity. This was performed using the MABA method against three strains i.e. Gram negative; Pseudomonas aeruginosa (ATCC 27853), Escherichia coli (ATCC 25922) and Gram positive; Staphylococcus aureus (ATCC 29213) using the broth micro dilution method. Standard antibiotics (ciprofloxacin and nalidixic acid) were used as positive controls and DMSO was used as a negative control. The results obtained from the anti-bacterial assay showed that compounds A4, A7 and A8 have high activity, whereas A2 and A3 showed poor activity against all the tested bacterial strains. Compound A6 showed no activity against S. aureus and E. coli.
M
Najir, Afraj Shakil, and Afraj Shakil Najir. "Development of A3 coupling and Strecker Reaction followed by 1,3 Dipolar Cycloaddition Reaction for Synthesis of Novel Fused Heterocyclic compounds." Thesis, 2016. http://ndltd.ncl.edu.tw/handle/7czr68.
Full text國立東華大學
化學系
104
The increasing environmental consciousness of the chemical community has led to the search for more efficient and environmentally friendly methods for chemical synthesis. This thesis describes the development of eco-friendly multicomponent coupling reactions and their utility in novel fused heterocyclic compounds synthesis. First chapter outlines a practical and efficient two-step protocol for the synthesis of several new fused triazoles. The first step involved AuBr3 catalyzed A3 coupling reaction at solvent-free condition to provide the requisite propargylamines with prominent features with high structural diversity, short reaction time, high diastereoselectivities and environmental benign. Further, propargylamines undergoes catalyst free intramolecular azide-alkyne cycloaddition reaction to give tricyclic fused triazoles with excellent yields and diastereoselectivity. Second chapter addresses a one-pot green and highly efficient method for the synthesis of propargylamines and diastereoselective synthesis of fused triazoles via A3 coupling reaction in the presence of Manganese(II) chloride as a catalyst and intramolecular [3+2] cycloaddition, respectively, without using a co-catalyst or activator is reported. This methodology is efficient, eco-friendly, operationally simple and effective for reactions involving aromatic, aliphatic, and heterocyclic aldehydes, and provides an easy access to propargylamines in excellent yields and fused triazoles in good yield and excellent diastereoselectivities. Third chapter highlights a method for the synthesis of propargylamines by a A3-coupling reaction followed by a [3+2] cycloaddition for the preparation of tricyclic fused triazoles. The A3 coupling uses Tin(II) chloride as the catalyst under solvent-free conditions to generate the desired products in good to excellent yields, this chapter also containes one more new method to synthesize series of novel isoxazoles through a Copper(II) acetylacetonate-catalyzed solvent-free A3 coupling reaction followed by intramolecular nitrile oxide-alkyne cycloaddition. This method demonstrates high structural diversity and generates desired products in satisfactory yields and diastereoselectivities. Fourth chapter describes efficient two-step method for synthesizing a series of new fused tetrazols by a catalyst-free three-component Strecker reaction followed by an intramolecular [3+2] cycloaddition. The first step involved three component coupling of aldehydes, (S)-2-(azidomethyl)pyrrolidine and potassium cyanide in presence of water to form aminonitriles. In the next step aminonitriles underwent intramolecular azide-nitrile cycloaddition to form fused tetrazoles. This methodology is cost-effective, operationally simple, and applicable for various aromatic, aliphatic and heterocyclic aldehydes, and gives desired products in satisfactory yields and diastereoselectivities.
Vicente, V., A. Fruchier, M. Taillefer, C. Coombes-Chamelet, Ian J. Scowen, F. Plenat, and H.-J. Cristeau. "Synthesis and structural studies (H-1, C-13, P-31 NMR and X-ray) of new C-bonded cyclotriphosphazenes with heterocyclic substituents from novel phosphinic acid derivatives." 2004. http://hdl.handle.net/10454/3552.
Full textThree new C-bonded cyclotriphosphazenes, [N3P3(2-thienyl)6], 2, [N3P3(3-thienyl)6], 4, and [N3P3(3,3-bithienyl-2,2-ylene)3], 6, have been prepared by two new synthetic procedures and are the first examples of non-spiro and trispirocyclotriphosphazene derivatives composed of thiophene and 3,3-dithiophene substituents, respectively. Their 1H, 13C and 31P NMR parameters are given. The solid state structures of 2, 4 and 6 have been determined by X-ray crystallography.
Machado, Vera Alexandra Pereira. "Synthesis of novel heterocyclic compounds based on rational design and evaluation of their antitumor and antiangiogenic potential in human endothelial and tumor cell lines with tyrosine kinase membrane receptors as targets." Doctoral thesis, 2016. http://hdl.handle.net/1822/44973.
Full textThe synthesis of novel 1-aryl-3-[3- or 4-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas was performed and they were first studied as potential antiangiogenics using Vascular Endothelium Growth Factor Receptor-2 (VEGFR-2) tyrosine kinase enzymatic assays. The most promising inhibitors, 1-aryl-3-[3-(thieno[3,2-b]pyridin-7-ylthio)phenyl]ureas, were also studied as antiangiogenics in endothelial cells (HUVECs) and as antitumorals against breast cancer cell lines. These compounds with the arylurea moiety in the metaposition relative to the thioether, showed the lowest IC50 values in enzymatic assays (10– 206 nM), the most potent compounds being those bearing hydrophobic groups (Me, F, CF3, CF3 and Cl) in the terminal phenyl ring (IC50 10–28 nM). A convincing rationalization as type II VEGFR-2 inhibitors was achieved by molecular docking, based on the simultaneous presence of: (1) the thioether linker and (2) the arylurea moiety in the meta-position. For all the compounds prepared with this type of substitutions, significant inhibition of HUVECs proliferation, migration and tube formation were observed at low concentrations (1.0-2.5 µM). Total and phosphorylated (active) VEGFR- 2 were detected by Western blotting, being the receptor phosphorylation significantly inhibited by these compounds at the same concentrations. An increase of apoptosis was also observed using TUNEL assay. Altogether, these outcomes point to an important antiangiogenic effect of these compounds in HUVECs. The antiproliferative properties of the compounds bearing hydrophobic groups were evaluated against two human breast cancer cell lines: hormone-dependent MCF-7 (ER positive) and MDA-MB-231 (ER/PR/HER2 - triple negative), the latter resulting from one of the most aggressive breast carcinomas with poor prognosis. The tested compounds suppressed breast cancer cell viability, proliferation, migration and colony formation at low concentrations (0.5-2.5 µM), without showing cytotoxicity in non-neoplastic human breast epithelial cells (MCF-10A). At the same concentrations, they induced apoptosis in MDA-MB-231 but not in MCF-7, and inhibited PI3K/Akt and MAPK/Erk signaling pathways in both breast cancer cell lines as observed by Western blotting. The findings of this work reveal a dual antitumor and antiangiogenic activity that is of paramount importance to the development of novel therapeutic strategies against breast cancer, rendering these compounds a relevant breakthrough for cancer therapy.
Sintetizaram-se novas 1-aril-3-[3- ou 4- (tieno[3,2-b]piridin-7-iltio)fenil]ureias e foram inicialmente estudadas como potenciais antiangiogénicos, usando ensaios enzimáticos de tirosina quinase do "Vascular Endothelium Growth Factor Receptor-2" (VEGFR-2). Os inibidores mais promissores, 1-aril-3-[3-(tieno[3,2-b]piridin-7-iltio)fenil]ureias, foram também estudados como antiangiogénicos em células endoteliais (HUVECs) e como antitumorais em linhas celulares de cancro da mama. Estes compostos com o grupo arilureia em posição meta em relação ao tioéter, apresentaram os menores valores de IC50 nos ensaios enzimáticos (10-206 nM), sendo os compostos que possuem grupos hidrofóbicos (Me, F, CF3, CF3 e Cl) no anel fenilo terminal, os mais potentes (IC50 10-28 nM). A racionalização convincente como inibidores tipo II de VEGFR-2 foi obtida por “docking” molecular, com base na presença simultânea: (1) da ligação tioéter e (2) do grupo arilureia em posição meta. Para todos os compostos com este tipo de substituições, observou-se uma significativa inibição da proliferação, migração e formação de túbulos em HUVECs a baixas concentrações (1.0-2.5 µM). A forma total e fosforilada (ativa) do VEGFR-2 foram detetadas por Western blotting, sendo a fosforilação do recetor significativamente inibida por estes compostos nas mesmas concentrações. Um aumento da apoptose foi também observado, utilizando o ensaio de TUNEL. Em conjunto, estes resultados mostram que estes compostos têm um importante efeito antiangiogénico em HUVECs. As propriedades antiproliferativas dos compostos com grupos hidrofóbicos foram avaliadas em duas linhas celulares de cancro da mama: hormonodependente MCF-7 (ER positivo) e MDA-MB-231 (ER/PR/HER2 – triplo negativo), sendo a última resultante de um dos carcinomas da mama mais agressivo e de mau prognóstico. Os compostos testados suprimem a viabilidade celular, proliferação, migração e a formação de colónias a concentrações baixas (0.5-2.5 µM), sem citotoxicidade em células epiteliais humanas de mama (MCF-10A). Nas mesmas concentrações, estes compostos induziram apoptose em MDA-MB-231, mas não em MCF-7 e inibiram as vias de sinalização PI3K/Akt e MAPK/Erk em ambas as linhas celulares, conforme observado por Western blotting. Os resultados deste trabalho revelam uma dupla atividade antitumoral e antiangiogénica, que é de suma importância para o desenvolvimento de novas estratégias terapêuticas para o cancro da mama, tornando estes compostos um avanço relevante para a terapia do cancro.
Fundação para a Ciência e a Tecnologia (FCT) - Portugal for the financial support through the Portuguese NMR network (Bruker 400 Avance III - Univ. Minho), to FCT and FEDER (European Found for Regional Development)- COMPETE/QREN/EU for the financial support through the research project PTDC/QUIQUI/ 111060/2009, and also to FCT, my PhD grant (SFRH/BD/77373/2011) also supported by POPH-QREN and FSE.
Sudhir, V. Sai. "Novel Strategies Towards Condenced Triazoles, Ferrocene Aminoacids, Conjugates And Selenosulfides." Thesis, 2009. http://hdl.handle.net/2005/1003.
Full text